Thermo Fisher Scientific Inc
TMO
Company Profile
Business description
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year end-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
Contact
168 Third Avenue
WalthamMA02451
USAT: +1 781 622-1000
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
125,000
Thermo Fisher Scientific Inc News & Analysis
markets
Q3 2025 US stock market outlook: After the rally, what’s still undervalued?
With valuations elevated and heightened volatility on the horizon, here’s how to position today.
stocks
The 10 best US companies to invest in now
These high-quality companies offer the best stocks to buy today.
stocks
10 cheap wide-moat US stocks for 2025
Undervalued high-quality names from the Morningstar Wide Moat Focus Index are attractive stocks to buy for long-term investors.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,812.10 | 63.20 | -0.71% |
| CAC 40 | 7,766.21 | 41.96 | -0.54% |
| DAX 40 | 24,060.29 | 100.35 | -0.42% |
| Dow JONES (US) | 44,023.29 | 436.36 | -0.98% |
| FTSE 100 | 8,938.32 | 59.74 | -0.66% |
| HKSE | 24,753.60 | 163.48 | 0.66% |
| NASDAQ | 20,677.80 | 37.47 | 0.18% |
| Nikkei 225 | 39,635.09 | 42.93 | -0.11% |
| NZX 50 Index | 12,754.20 | 64.57 | 0.51% |
| S&P 500 | 6,243.76 | 24.80 | -0.40% |
| S&P/ASX 200 | 8,562.40 | 67.90 | -0.79% |
| SSE Composite Index | 3,501.63 | 3.37 | -0.10% |